Potential role of Renin-Angiotensin-system in receptor negative breast for tumor angiogenesis cancer

被引:74
作者
Herr, D. [1 ]
Rodewald, M. [1 ]
Fraser, H. M. [2 ]
Hack, G.
Konrad, R. [1 ]
Kreienberg, R. [1 ]
Wulff, C. [1 ]
机构
[1] Univ Ulm, Med Ctr, Dept Obstet & Gynecol, D-89075 Ulm, Germany
[2] Queens Med Res Inst, Med Res Council Human Reproduct Sci Unit, Edinburgh EH16 4TJ, Midlothian, Scotland
基金
英国医学研究理事会;
关键词
breast cancer cell; angiogenesis; Angiotensin II; inhibition; Candesartan;
D O I
10.1016/j.ygyno.2008.02.019
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Objective. This study examined the potential role of Angiotensin 11 for the regulation of angiogenesis associated genes in receptor positive and negative human breast cancer. Methods. Expression of different Renin-Angiotensin system (R-AS) components in human breast cancer tissue was investigated using immunofluorescence, and in a receptor positive (MCF-7) and receptor negative (NIDA-MB 468) breast cancer cell line by perfortning immunocytochemistry and RT-PCR. Both cell lines were stimulated with Angiotensin 11 and Angiotensin 11 receptor type I (At, R) blocker Candesartan, and geneexpression of vascular endothelial growth factor(VEGF), Angiopoietin I and 2 (Ang-1 and Ang-2), tissue inhibitor of matrix metalloprotemases I (TIMP-1), and hypoxia inducible transcription factor 2 alpha (HIF-2 alpha) were quantified by TaqMan-Real-Time PCR analysis. Results. RAS components, Angiotensinogen, Renin, Angiotensin I-converting enzyme (ACE), and At1R and At2R were expressed in homonereceptor negative and positive human breast cancer tissue as well as in MDA-MB 468 and in MCF-7 human breast cancer cells. In addition, we found expression of VEGF, Ang-1, TIMPA,-1 and HIF-2 alpha in both cell lines. However, only in receptor negative MDA-MB 468 cells, did Angiotensin II significantly increase gene expression of VEGF, HIF-2 alpha, and TIMP-1 This effect was completely inhibited by Candesartan. Conclusion. In conclusion, it is hypothesized that Angiotensin 11 may be involved in regulation of tumor angiogenesis especially in receptor negative breast cancer by regulation of angiogenesis associated genes via At1R. These findings are the first evidence for targeting tumor angiogenesis by inhibition of At1R in receptor negative human breast cancer cells and may lead to new therapeutical anticancer strategies based upon inhibition of At1R. (c) 2008 Elsevier Inc. All rights reserved.
引用
收藏
页码:418 / 425
页数:8
相关论文
共 44 条
[41]   Angiotensin-I-converting enzyme inhibitors may be an alternative anti-angiogenic strategy in the treatment of liver fibrosis and hepatocellular carcinoma - Possible role of vascular endothelial growth factor [J].
Yoshiji, H ;
Kuriyama, S ;
Fukui, H .
TUMOR BIOLOGY, 2002, 23 (06) :348-356
[42]  
Yoshiji H, 2001, CLIN CANCER RES, V7, P1073
[43]   Green tea intake, ACE gene polymorphism and breast cancer risk among Chinese women in Singapore [J].
Yuan, JM ;
Koh, WP ;
Sun, CL ;
Lee, HP ;
Yu, MC .
CARCINOGENESIS, 2005, 26 (08) :1389-1394
[44]   Vascular endothelial growth factor overexpression by soft tissue sarcoma cells: Implications for tumor growth, metastasis, and chemoresistance [J].
Zhang, Lianglin ;
Hannay, Jonathan A. F. ;
Liu, Juehui ;
Das, Parimal ;
Zhan, Maocheng ;
Nguyen, Theresa ;
Hicklin, Daniel J. ;
Yu, Dihua ;
Pollock, Raphael E. ;
Lev, Dina .
CANCER RESEARCH, 2006, 66 (17) :8770-8778